相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small Molecule Inhibition of GSK-3 Specifically Inhibits the Transcription of Inhibitory Co-receptor LAG-3 for Enhanced Anti-tumor Immunity
Christopher E. Rudd et al.
CELL REPORTS (2020)
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells
Alison Taylor et al.
BMC RESEARCH NOTES (2020)
Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy
Alison Taylor et al.
CANCER RESEARCH (2018)
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy
Alison Taylor et al.
FRONTIERS IN IMMUNOLOGY (2017)
GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?
Ana Martinez et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
T-cell development is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages
Y. Jeffrey Chiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8+ Cytolytic T Cell Responses
Alison Taylor et al.
IMMUNITY (2016)
Regulation of Th1 Cells and Experimental Autoimmune Encephalomyelitis by Glycogen Synthase Kinase-3
Eleonore Beurel et al.
JOURNAL OF IMMUNOLOGY (2013)
Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase Kinase-3α
Fabio Lo Monte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Glycogen Synthase Kinase-3 Is an Early Determinant in the Differentiation of Pathogenic Th17 Cells
Eleonore Beurel et al.
JOURNAL OF IMMUNOLOGY (2011)
GSK-3 inhibitors: preclinical and clinical focus on CNS
Hagit Eldar-Finkelman et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Glycogen synthase kinase 3: more than a namesake
Geetha Vani Rayasam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
New insights into the regulation and function of serine/threonine kinases in T lymphocytes
Sharon A. Matthews et al.
IMMUNOLOGICAL REVIEWS (2009)
TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1
Joanne E. Wood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3
M Martin et al.
NATURE IMMUNOLOGY (2005)
Role that phosphorylation of GSK3 plays in insulin
EJ McManus et al.
EMBO JOURNAL (2005)
Antigen-driven effector CD8 T cell function regulated by T-bet
BM Sullivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
LJ Appleman et al.
JOURNAL OF IMMUNOLOGY (2002)
CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium
CA Grimes et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc
JW Neal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3
T Ohteki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
